These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23229860)

  • 1. Celiac disease: a challenging disease for pharmaceutical scientists.
    Matoori S; Fuhrmann G; Leroux JC
    Pharm Res; 2013 Mar; 30(3):619-26. PubMed ID: 23229860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological approaches in celiac disease.
    McCarville JL; Caminero A; Verdu EF
    Curr Opin Pharmacol; 2015 Dec; 25():7-12. PubMed ID: 26414923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiac Disease and Gluten Sensitivity.
    DeGeorge KC; Frye JW; Stein KM; Rollins LK; McCarter DF
    Prim Care; 2017 Dec; 44(4):693-707. PubMed ID: 29132529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adult Celiac Disease].
    Many N; Biedermann L
    Praxis (Bern 1994); 2016 Jul; 105(14):803-10; quiz 809-12. PubMed ID: 27381303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
    Koning F; Gilissen L; Wijmenga C
    Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase as a therapeutic target for celiac disease.
    Sulic AM; Kurppa K; Rauhavirta T; Kaukinen K; Lindfors K
    Expert Opin Ther Targets; 2015 Mar; 19(3):335-48. PubMed ID: 25410283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
    Schuppan D; Dennis MD; Kelly CP
    Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic strategies for coeliac disease: tissue transglutaminase as a target.
    Esposito C; Caputo I; Troncone R
    Curr Med Chem; 2007; 14(24):2572-80. PubMed ID: 17979710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluten Degrading Enzymes for Treatment of Celiac Disease.
    Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of celiac disease in daily clinical practice.
    Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
    Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic approaches for celiac disease.
    Vanga RR; Kelly CP
    Discov Med; 2014 May; 17(95):285-93. PubMed ID: 24882720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiac disease: advances in treatment via gluten modification.
    Stoven S; Murray JA; Marietta E
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):859-62. PubMed ID: 22728383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.
    McAllister BP; Williams E; Clarke K
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):226-243. PubMed ID: 29858750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
    Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
    Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
    Siegel M; Xia J; Khosla C
    Bioorg Med Chem; 2007 Sep; 15(18):6253-61. PubMed ID: 17590341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques.
    Sestak K; Thwin H; Dufour J; Liu DX; Alvarez X; Laine D; Clarke A; Doyle A; Aye PP; Blanchard J; Moehs CP
    Nutrients; 2016 Jun; 8(7):. PubMed ID: 27367722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiac disease 2015 update: new therapies.
    Veeraraghavan G; Leffler DA; Kaswala DH; Mukherjee R
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):913-27. PubMed ID: 25864708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the timing of gluten introduction on the development of celiac disease.
    Silano M; Agostoni C; Guandalini S
    World J Gastroenterol; 2010 Apr; 16(16):1939-42. PubMed ID: 20419830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.